NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,172,612 | -3.8% | 11,512 | -4.7% | 0.11% | -1.7% |
| Q2 2023 | $1,219,497 | +11.2% | 12,085 | +1.4% | 0.12% | +1.8% |
| Q1 2023 | $1,096,272 | -2.4% | 11,916 | -3.8% | 0.11% | -6.6% |
| Q4 2022 | $1,123,295 | +17.1% | 12,382 | -1.9% | 0.12% | +15.1% |
| Q3 2022 | $959,000 | -11.1% | 12,619 | -1.1% | 0.11% | -5.4% |
| Q2 2022 | $1,079,000 | -10.3% | 12,765 | -6.9% | 0.11% | +3.7% |
| Q1 2022 | $1,203,000 | +3.4% | 13,707 | +3.1% | 0.11% | +4.9% |
| Q4 2021 | $1,163,000 | +15.5% | 13,298 | +12.0% | 0.10% | +14.4% |
| Q3 2021 | $1,007,000 | -1.8% | 11,872 | -1.1% | 0.09% | -26.8% |
| Q1 2021 | $1,025,000 | -12.5% | 12,003 | -3.2% | 0.12% | -20.1% |
| Q4 2020 | $1,171,000 | +14.0% | 12,397 | +5.0% | 0.15% | -17.6% |
| Q3 2020 | $1,027,000 | +3.4% | 11,805 | +3.9% | 0.19% | -42.1% |
| Q2 2020 | $993,000 | -15.3% | 11,366 | -19.7% | 0.32% | -8.2% |
| Q1 2020 | $1,173,000 | -15.6% | 14,155 | -3.5% | 0.35% | -5.9% |
| Q4 2019 | $1,389,000 | – | 14,673 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |